• PDF / 133,999 Bytes
• 1 Pages / 623.591 x 841.847 pts Page_size
• 5 Downloads / 183 Views

DOWNLOAD

REPORT

1173-5503/10/0518-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved

PharmacoEconomics & Outcomes News 16 Dec 2006 No. 518

1

Recommend Documents

Living with Advanced Hormone-Sensitive Prostate Cancer and Treatment with Abiraterone and Androgen Deprivation Therapy:

170 74 504KB

HSD3B1 variant and androgen-deprivation therapy outcome in prostate cancer

178 5 2MB

Toxicity of Androgen Deprivation Therapy in Hormone-Sensitive Prostate Cancer

204 15 418KB

Combination of Androgen Deprivation Therapy and Radiation Therapy for Locally Advanced and Localized Prostate Cancer

180 96 16MB

Androgen Deprivation Therapy

180 84 7MB

[ 18 F]-JK-PSMA-7 PET/CT Under Androgen Deprivation Therapy in Advanced Prostate Cancer

175 84 3MB

Androgen deprivation therapy increases risk of dementia

149 19 166KB

Androgen Action in Prostate Cancer

161 61 53MB

Monitoring and Managing Men Following Initial Treatment of Prostate Cancer

113 84 7MB

Endocrine consequences of treatment with the new androgen receptor axis-targeted agents for advanced prostate cancer

192 0 507KB

HIV Prevention, Care, and Treatment Among Black Men Who Have Sex with Men (MSM)

104 68 3MB

Dementia risk varies by type of androgen deprivation therapy

175 3 148KB